Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,625 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1997 Feb;24(2):328-32. J Rheumatol. 1997. PMID: 9034992
Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients.
Matsui C, Ida M, Hamada M, Morohashi M, Hasegawa M. Matsui C, et al. Among authors: hasegawa m. Int J Dermatol. 1994 Dec;33(12):868-71. doi: 10.1111/j.1365-4362.1994.tb01025.x. Int J Dermatol. 1994. PMID: 7883414 Clinical Trial.
Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis.
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1997 Apr;24(4):663-5. J Rheumatol. 1997. PMID: 9101498
Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma.
Hasegawa M, Takata M, Hatta N, Wakamatsu K, Ito S, Takehara K. Hasegawa M, et al. Melanoma Res. 1997 Jun;7(3):243-51. doi: 10.1097/00008390-199706000-00009. Melanoma Res. 1997. PMID: 9195564
Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1998 Feb;25(2):308-13. J Rheumatol. 1998. PMID: 9489824
OBJECTIVE: To determine whether serum interleukin 6 (IL-6), oncostatin M (OSM), soluble IL-6 receptor (sIL-6R), and soluble gp130 (sgp130) levels in patients with systemic sclerosis (SSc) are elevated and whether they are correlated with the clinical or serological feature …
OBJECTIVE: To determine whether serum interleukin 6 (IL-6), oncostatin M (OSM), soluble IL-6 receptor (sIL-6R), and soluble gp130 (sg …
Increased plasma granulocyte elastase levels in Behçet's disease.
Tsutsui K, Hasegawa M, Takata M, Takehara K. Tsutsui K, et al. Among authors: hasegawa m. J Rheumatol. 1998 Feb;25(2):326-8. J Rheumatol. 1998. PMID: 9489828
IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis.
Takamatsu Y, Hasegawa M, Sato S, Takehara K. Takamatsu Y, et al. Among authors: hasegawa m. Dermatology. 1998;196(4):377-81. doi: 10.1159/000017928. Dermatology. 1998. PMID: 9669111
Antigen specificity of antihistone antibodies in systemic sclerosis.
Hasegawa M, Sato S, Kikuchi K, Takehara K. Hasegawa M, et al. Ann Rheum Dis. 1998 Aug;57(8):470-5. doi: 10.1136/ard.57.8.470. Ann Rheum Dis. 1998. PMID: 9797552 Free PMC article.
Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S, Hasegawa M, Nagaoka T, Takamatsu Y, Yazawa N, Ihn H, Kikuchi K, Takehara K. Sato S, et al. Among authors: hasegawa m. J Rheumatol. 1998 Nov;25(11):2135-9. J Rheumatol. 1998. PMID: 9818655
Systemic sclerosis revealing T-cell lymphoma.
Hasegawa M, Sato S, Sakai H, Ohashi T, Takehara K. Hasegawa M, et al. Dermatology. 1999;198(1):75-8. doi: 10.1159/000018070. Dermatology. 1999. PMID: 10026408
3,625 results
Jump to page
Feedback